The Discounted Cash Flow (DCF) valuation of HPGC Renmintongtai Pharmaceutical Corp (600829.SS) is 27.04 CNY. With the latest stock price at 7.40 CNY, the upside of HPGC Renmintongtai Pharmaceutical Corp based on DCF is 265.4%.
Based on the latest price of 7.40 CNY and our DCF valuation, HPGC Renmintongtai Pharmaceutical Corp (600829.SS) is a buy. buying 600829.SS stocks now will result in a potential gain of 265.4%.
| Range | Selected | |
| WACC / Discount Rate | 4.9% - 6.9% | 5.9% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 17.44 - 56.47 | 27.04 |
| Upside | 135.7% - 663.1% | 265.4% |